NasdaqCM:SLGLPharmaceuticals
Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative
Sol-Gel Technologies (NasdaqCM:SLGL) opened 2026 with Q1 revenue of US$0.1 million and a basic EPS loss of US$1.31, while net income excluding extra items was a loss of US$3.7 million. Over the past five reported quarters, the company has seen revenue move between US$0.1 million and US$17.3 million, with basic EPS ranging from a loss of US$3.16 to a gain of US$4.17 per share and trailing 12 month EPS sitting at a loss of US$0.37. For investors, this quarter focuses on how a small top line and...